CN Patent
CN104523683B — 一种盐酸可乐定干混悬剂及其制备方法
Assigned to Qingdao Guoxin Pharmaceutical Co ltd · Expires 2017-05-17 · 9y expired
What this patent protects
本发明提供了一种盐酸可乐定干混悬剂及其制备方法,所述盐酸可乐定干混悬剂包括:盐酸可乐定40-90份,填充剂500-2000份,矫味剂50-180份,助悬剂40-100份,絮凝剂10-40份。本发明盐酸可乐定干混悬剂分布均匀、稳定性好、在胃肠的分布面积大、吸收快、生物利用度高、药物起效快、药效优于盐酸可乐定预混剂。
USPTO Abstract
本发明提供了一种盐酸可乐定干混悬剂及其制备方法,所述盐酸可乐定干混悬剂包括:盐酸可乐定40-90份,填充剂500-2000份,矫味剂50-180份,助悬剂40-100份,絮凝剂10-40份。本发明盐酸可乐定干混悬剂分布均匀、稳定性好、在胃肠的分布面积大、吸收快、生物利用度高、药物起效快、药效优于盐酸可乐定预混剂。
Drugs covered by this patent
- Catapres-Tts-1 (CLONIDINE) · Lavipharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.